Search Results 11-20 of 16285 for nivolumab
Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells. Participation eligibility. Participant ...
The purpose of this study is to determine whether nivolumab alone or in combination with standard of care therapies will provide clinical benefit without ...
About this study. This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a ...
Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation therapy may kill more cancer cells.
Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ability ...
The findings support further development of nivolumab, which enhances the immune system's ability to detect and kill cancer cells. The drug has already ...
A combined treatment with nivolumab and ipilimumab, chemotherapy, and radiation therapy might be more effective in patients with esophageal and gastroesophageal ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving copanlisib and nivolumab may work better in ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.